Synacthen

Questcor Pays $135 Million to Acquire Rights to a Competitor’s Drug
NY Times
Sat, 06/15/13 - 01:13 pm
Questcor Pharmaceuticals
Synacthen
Novartis
H.P. Acthar Gel
Questcor Surges on Drug Acquisition
Yahoo/Zacks
Wed, 06/12/13 - 12:48 pm
M&A
Questcor
Synacthen
Novartis
Questcor Surges After Acquiring Rights to Novartis Drug
Bloomberg
Tue, 06/11/13 - 10:41 am
Questcor
Novartis
Synacthen
autoimmune disease
ulcerative colitis